Interpace Biosciences Announces Full Year and Fourth Quarter 2019 Financial and Business Results and Preliminary Q1-2020 Results
INTERPACE BIOSCIENCES INC (IDXG)
Last interpace biosciences inc earnings: 11/13 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
interpacediagnostics.com/investors
Company Research
Source: GlobeNewswire
Acquired Biopharma Business of Cancer Genetics in Second Half of 2019 Through Q1-2020 Raised $47 million from Two Top Private Equity FirmsProvides First Quarter 2020 Range of Revenues Expects to Launch COVID-19 Serology Testing in Q2-2020Robert Gorman, Diagnostic Industry Expert, Appointed Chairman of the BoardWithdraws Full-Year 2020 Guidance Conference Call and Webcast Wednesday April 22, 2020 5:00 pm ET PARSIPPANY, NJ, April 22, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG) today announced financial results for the fiscal year ended December 31, 2019 and provided a business and financial update. “Fiscal 2019 was a transformational year for us as we acquired the Biopharma business of Cancer Genetics in July and raised over $47 million from sophisticated laboratory private equity investors in 2019 and early 2020. We believe that the combination of our clinical services and acquired pharma services uniquely positions us for growth and expansion in the
Show less
Read more
Impact Snapshot
Event Time:
IDXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IDXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IDXG alerts
High impacting INTERPACE BIOSCIENCES INC news events
Weekly update
A roundup of the hottest topics
IDXG
News
- Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners [Yahoo! Finance]Yahoo! Finance
- Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital PartnersGlobeNewswire
- Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M [Seeking Alpha]Seeking Alpha
- Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results [Yahoo! Finance]Yahoo! Finance
- Interpace Biosciences Announces Third Quarter 2025 Financial and Business ResultsGlobeNewswire
IDXG
Sec Filings
- 12/3/25 - Form 8-K
- 11/12/25 - Form 8-K
- 11/12/25 - Form 10-Q
- IDXG's page on the SEC website